Insight

Latest California Healthline Stories

Proposed PFAS Rule Would Cost Companies Estimated $1B; Lacks Limits and Cleanup Requirement

A proposed Environmental Protection Agency rule calls for companies to disclose PFAS manufactured or imported since 2011. The chemical industry is upset because such compliance would cost an estimated $1 billion, while environmental health advocates worry because the rule wouldn’t ban the chemicals outright.

Meet the People Deciding How to Spend $50 Billion in Opioid Settlement Cash

As settlement dollars land at the state level, state councils wield significant power in determining how the windfall gets spent. And, though they will likely include the most knowledgeable voices on addiction, these panels also face concerns about conflicts of interest and other issues.

Medi-Cal’s Fragmented System Can Make Moving a Nightmare

When Medi-Cal beneficiary Lloyd Tennison moved last year from Contra Costa County to San Joaquin County, he was bumped off his managed care plan without notice before his new coverage took effect. His case highlights a chronic issue in California’s fragmented Medicaid program.

Patients Squeezed in Fight Over Who Gets to Bill for Pricey Infusion Drugs

To drive down costs, insurers are bypassing hospital system pharmacies and delivering high-priced infusion drugs, including some used in chemotherapy, via third-party pharmacies. Smarting from losing out on billing for those drugs, hospitals and clinics are trying to convince states to limit this practice, known as “white bagging.”

A New Law Is Supposed to Protect Pregnant Workers — But What If We Don’t Know How?

During pregnancy, workers often face hazardous circumstances, including breathing toxic chemicals. On June 27, the Pregnant Workers Fairness Act began requiring employers to provide “reasonable accommodations.” But the new law has a big hole: Not nearly enough is known about which chemical exposures are dangerous for pregnant workers.